Regional action needed to halt antimalarial drug resistance in Africa.Martinez-Vega R, Ishengoma DS, Gosling R, Rosenthal PJ, Dondorp A, Barnes KI, Nsanzabana C, Djimde AA, Ochola-Oyier LI, Tibenderana J, Chimumbwa J, Golassa L, Kapologwe NA, Mbacham WF, Kamya MR, Fidock DA, Komatsu R, von Seidlein L, Dhorda M
Lancet, (2025). 405:7-10
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.Coldiron ME, Soumana I, Baudin E, Langendorf C, Mamiafo Tchoula C, Brah S, Karani A, Gallagher KE, Kagucia EW, Scott JAG, Grais RF
Lancet Infect Dis, (2025). 24:S1473-3099
Repeatability of RRate measurements in children during triage in two Ugandan hospitals.Asdo A, Mawji A, Omara I, Aye Ishebukara IA, Komugisha C, Novakowski SK, Pillay Y, Wiens MO, Akech S, Oyella F, Tagoola A, Kissoon N, Ansermino JM, Dunsmuir D
PLOS Glob Public Health, (2025). 5:e0003097
Malaria prophylaxis in sickle cell anaemia: some answers, more questions.Williams TN, Ware RE
Lancet Infect Dis, (2024). 24:S1473-3099
Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity.Otieno JA, Were L, Nyanchoka M, Olwanda E, Mulaku M, Sem X, Kohli M, Markby J, Muriuki A, Ochodo E
Front Public Health, (2024). 12:1439164
Malaria Prevention for Pregnant Women and Under-Five Children in 10 Sub-Saharan Africa Countries: Socioeconomic and Temporal Inequality Analysis.Okova D, Lukwa AT, Oyando R, Bodzo P, Chiwire P, Alaba OA
Int J Environ Res Public Health, (2024). 21:
The association of polytherapy and psychiatric comorbidity in epilepsy.Odhiambo MA, Kaingu GK, Mumbo M, Kipper K, Sander JW, Newton CRJC, Kariuki SM, EPInA investigators
Epilepsy Behav, (2024). 163:110215
Coming to terms with climate change: a glossary for climate change impacts on mental health and well-being.Niedzwiedz CL, Olsen JR, Rizeq J, Afework T, Hill-Harding CKV, Shaw RJ, Thomas R, Kariuki SM, Katikireddi SV, Weaver AJ, Martin G, Parr H, Papies EK
J Epidemiol Community Health, (2024). 79:295-301
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J
BMC Infect Dis, (2024). 24:1474
The discrepancy of antemortem clinical diagnosis and postmortem autopsy diagnosis of lung pathologies in under-five deaths and the reasons for discrepancies: a case series analysis.Leulseged H, Rees CA, Alemu A, Tippett Barr BA, Dheresa M, Madrid L, Scott A, Assefa N
BMC Pediatr, (2024). 24:365
Examining patient choice and provider competition under the National Health Insurance Fund outpatient cover in Kenya: does it enhance access and quality of care?.Kazungu J, Barasa E, Quaife M, Nonvignon J
BMC Health Serv Res, (2024). 24:1569
Assessing the scalability of health system interventions in Africa: protocol for a Delphi study.Karamagi HC, Charif AB, Kidane SN, Berhane A, Nzinga J, Yohannes T, Moyo TN, Sy S, Kipruto HK
Health Res Policy Syst, (2024). 22:176
The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021.Global Burden of Disease Study Autism Spectrum Collaborators
Lancet Psychiatry, (2024). 12:111-121
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families.Jemutai J, Downs L, Anderson M, Cohen C, Seeley J, Sultan B, Ko J, Flanagan S, Iwuji C, Halford R, Fernandes O, Vickerman P, Johannessen A, Matthews PC
Lancet Gastroenterol Hepatol, (2024). 10:100-103
Using theory to understand how interventions work and inform future implementation.Graham HR, Oliwa J
Lancet Glob Health, (2024). 13:e177-e178
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Munoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arova L, Mackenzie GA, Eugenia Leon M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacon G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL, Deloria Knoll M, Pserenade Team
Lancet Infect Dis, (2024). 24:445-456
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.Bennett JC, Deloria Knoll M, Kagucia EW, Garcia Quesada M, Zeger SL, Hetrich MK, Yang Y, Herbert C, Ogyu A, Cohen AL, Yildirim I, Winje BA, von Gottberg A, Viriot D, van der Linden M, Valentiner-Branth P, Suga S, Steens A, Skoczynska A, Sinkovec Zorko N, Scott JA, Savulescu C, Savrasova L, Sanz JC, Russell F, Ricketson LJ, Puentes R, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mad'arova L, Mackenzie GA, MacDonald L, Lepp T, Ladhani SN, Kristinsson KG, Kozakova J, Klein NP, Jayasinghe S, Ho PL, Hilty M, Heyderman RS, Hasanuzzaman M, Hammitt LL, Guevara M, Grgic-Vitek M, Gierke R, Georgakopoulou T, Galloway Y, Diawara I, Desmet S, De Wals P, Dagan R, Colzani E, Cohen C, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Bigogo G, Ampofo K, O'Brien KL, Feikin DR, Hayford K, Pserenade Team
Lancet Infect Dis, (2024). 25:457-470
What will it take? Perspectives from five low- and middle-income countries on opportunities and challenges of introducing new maternal vaccines.Baral R, Fleming JA, Barros I, Cofie P, Dapaah P, Khan S, Knudson SJ, Kumar S, Mehedi K, Munywoki PK, Newhouse L, Nyawanda BO, Nyiro JU, Odiyo J, Otiang E, Owusu R, Pecenka C, Picolo M, Pinto J, Quelhas D, Routray S, Sultana S, Uranw S
Vaccine, (2024). 45:126654
Integrating alternative and complementary medicine in the management of epilepsy and its comorbidities in low- and middle-income settings.Kariuki SM, Newton CRJC
Epilepsy Behav, (2025). 162:110172
Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.Nazziwa J, Freyhult E, Hong MG, Johansson E, Årman F, Hare J, Gounder K, Rezeli M, Mohanty T, Kjellström S, Kamali A, Karita E, Kilembe W, Price MA, Kaleebu P, Allen S, Hunter E, Ndung'u T, Gilmour J, Rowland-Jones SL, Sanders E, Hassan AS, Esbjörnsson J
Nat Commun, (2024). 15:10593
